Salix Pharmaceuticals is one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal (GI) diseases. We offer effective solutions and strive to be the first to discover what patients need next.
We gain a deeper understanding of the GI conditions our products treat by connecting with the patients who use them and the healthcare professionals (HCPs) who prescribe them. Our therapeutic areas of expertise include management of conditions such as hepatic encephalopathy, irritable bowel syndrome with diarrhea, opioid-induced constipation, and ulcerative colitis.
We employ dedicated and innovated team members who are driven to solve problems. We improve upon existing treatments, uncover new breakthroughs, and deliver comprehensive practice support to help HCPs provide best-in-class care.
The landscape of healthcare will continue to change and new patients will continue to present with new needs. That’s why there is no finish line for our innovation and no limits to our potential.